We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+8.67%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$2.51B
AUM Growth
+$357M
Cap. Flow
+$268M
Cap. Flow %
10.68%
Top 10 Hldgs %
89.42%
Holding
45
New
1
Increased
3
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$466M
2
FRSH icon
Freshworks
FRSH
+$172M
3
PRME icon
Prime Medicine
PRME
+$24.3M
4
GUTS icon
Fractyl Health
GUTS
+$5.58M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$238M
2
CRWD icon
CrowdStrike
CRWD
+$131M
3
OSCR icon
Oscar Health
OSCR
+$15.7M
4
NMRA icon
Neumora Therapeutics
NMRA
+$6.9M
5
IVVD icon
Invivyd
IVVD
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 62.03%
2 Healthcare 34.22%
3 Industrials 3.63%
4 Consumer Staples 0.12%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNYA icon
26
Tenaya Therapeutics
TNYA
$161M
$4.79M 0.19%
915,705
– –
AUTL
27
Autolus Therapeutics
AUTL
$375M
$4.45M 0.18%
698,262
– –
BRNS
28
Barinthus Biotherapeutics
BRNS
$24.6M
$3.6M 0.14%
1,513,644
– –
FHTX icon
29
Foghorn Therapeutics
FHTX
$294M
$3.36M 0.13%
500,901
– –
BHIL
30
DELISTED
Benson Hill, Inc.
BHIL
$3.07M 0.12%
438,636
– –
KRON
31
DELISTED
Kronos Bio
KRON
$1.87M 0.07%
1,438,232
– –
TSHA icon
32
Taysha Gene Therapies
TSHA
$1.54B
$1.84M 0.07%
640,882
– –
EXAS
33
DELISTED
Exact Sciences
EXAS
$1.6M 0.06%
23,205
– –
SPRO icon
34
Spero Therapeutics
SPRO
$67.7M
$1.53M 0.06%
889,979
– –
RANI icon
35
Rani Therapeutics
RANI
$88.1M
$1.39M 0.06%
448,492
– –
ALEC icon
36
Alector
ALEC
$165M
$1.06M 0.04%
175,866
– –
HYPR icon
37
Hyperfine
HYPR
$93.5M
$899K 0.04%
898,720
– –
QNCX icon
38
Quince Therapeutics
QNCX
$17.3M
$200K 0.01%
946
– –
FULC icon
39
Fulcrum Therapeutics
FULC
$243M
$135K 0.01%
14,262
– –
RGEN icon
40
Repligen
RGEN
$8.39B
$70.4K ﹤0.01%
383
– –
MOND
41
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$42.5K ﹤0.01%
18,420
– –
HLTH
42
DELISTED
Cue Health Inc. Common Stock
HLTH
$5.13K ﹤0.01%
27,000
– –
NMRA icon
43
Neumora Therapeutics
NMRA
$304M
– –
-404,732
Closed -$6.9M
SNCE
44
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-160,364
Closed -$856K
NVTA
45
DELISTED
Invitae Corporation
NVTA
$0 ﹤0.01%
235,606
– –
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q1 2024 Portfolio in Review

As of Q1 2024, Alphabet Inc held 45 positions worth $2.51B, up 17% from $2.16B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Alphabet Inc deployed $268M of net new capital in Q1 2024, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Fractyl Health: 662,584 shares worth $4.9M.

By sector, the portfolio is most concentrated in Technology at 62% of assets, up from 47% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was DexCom, an estimated $238M trimmed.

  • Alphabet Inc's largest Q1 2024 buy was Fractyl Health: 662,584 shares worth $4.9M.
  • Alphabet Inc added most to GitLab in Q1 2024, an estimated $466M increase.
  • Alphabet Inc's biggest Q1 2024 reduction was DexCom, cutting an estimated $238M.
  • Alphabet Inc fully exited Neumora Therapeutics in Q1 2024, selling an estimated $6.9M.
  • Alphabet Inc's ten largest holdings make up 89% of its $2.51B portfolio in Q1 2024.
  • Alphabet Inc opened 1 new position and closed 2 in Q1 2024.
  • Alphabet Inc's portfolio value rose 17% quarter-over-quarter to $2.51B.

Based on Alphabet Inc's 13F filing for Q1 2024, filed 3 May 2024.